Pathway Financial Advisors LLC Bristol Myers Squibb CO Transaction History

Pathway Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	BUY	$72.62 - $79.98 $198,325 - $218,425	2,731 New	2,731 $210,000
Q2 2020 Jul 21, 2020	SELL	$54.82 - $64.09 $200,915 - $234,889	-3,665 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $180,354 - $235,256	3,665 New	3,665 $247,000
Q3 2018 Jan 16, 2019	SELL	$55.19 - $62.25 $89,131 - $100,533	-1,615 Closed	0 $0
Q4 2017 May 04, 2018	BUY	$59.94 - $65.35 $96,803 - $105,540	1,615	1,615 $99,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Pathway Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pathway Financial Advisors LLC with notifications on news.